Mathias Haarhaus retweeted
🏆Congratulations @mjlloretcora !!!! #bestabstract award in the 6º EUROD Winter Meeting #CKDMBD @ERAkidney @SENefrologia @nefrocat @senjoven
Mathias Haarhaus retweeted
Amazing talk by @LucileFigueres on calcium and magnésium in CKD during the EUROD meeting in Leuven! #EUROD @FiliereOSCAR @FiliereORKiD
Advanced CKD no longer an obstacle for osteoporosis treatment? See new recommendations by IOF & ERA-EDTA: Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism | SpringerLink link.springer.com/article/10…
Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment - Kidney International. The underlying cause may determine the association of low bone turnover with outcome, which is not always unfafourable. kidney-international.org/art…
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D | Nephrology Dialysis Transplantation | Oxford Academic. academic.oup.com/ndt/advance…
ASN in beautiful Washington D.C.
Proud team presenting exciting new data on a strong association of serum ALP with cognitive impairment (R^2=0.96) in the baseline assessment of BETonMACE
First report ever of a clinical intervention that lowers alkaline phosphatase and improves cardiovascular outcome in patients with CVD.
Is this the humble start of a new therapeutic paradigm: targeting ALP for cardiovascular risk reduction?
Joint effort to improve outcome for CKD patients. nitter.cf/kamkalantar/status/864…
Nature Reviews Nephrol hot: Alkaline Phosphatase (#ALP) strikes back in CKD a novel treatment target for CV disease nature.com/nrneph/journal/va…
1













